Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 12/20 | 0.54 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887073 | 0.85 | ACE (0.40) | ACE | |
| SCHEMBL16527291 | 0.85 | TSHR (0.42) | ACEFKBP1ACYP2C19 | |
| SCHEMBL4658185 | 0.83 | ACE (0.37) | ACEPOLBKMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL15320610 | 0.81 | ACE (0.36) | ACE | |
| SCHEMBL9485556 | 0.80 | PIK3CD (0.34) | ACEKMT2A | |
| SCHEMBL9000514 | 0.78 | CYP3A4 (0.37) | KMT2AL3MBTL1 | |
| SCHEMBL7355166 | 0.77 | SMN1; SMN2 (0.32) | ACEKMT2ASMN1; SMN2LMNA | |
| SCHEMBL8368471 | 0.77 | CHRNA7 (0.35) | L3MBTL1 | |
| Water SCHEMBL28388741 | 0.76 | ALDH1A1 (0.33) | KMT2ASMN1; SMN2LMNA | |
| SCHEMBL9286164 | 0.76 | ACE (0.50) | ACEFKBP1APOLBCYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719357-A1 | COMPOSITIONS COMPRISING SOTORASIB | Amgen Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2024249660-A1 | COMPOSITIONS COMPRISING SOTORASIB | AMGEN INC. (US) | 2024-12-05 | — | — | WO | claimed |
| EP-2680823-B1 | BINDER POWDERS | NANO4M LTD (GB) | 2024-05-15 | — | — | EP | claimed |
| EP-4048247-B1 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF FINGOLIMOD | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2024-04-03 | — | — | EP | claimed |
| EP-4076382-B1 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2024-03-20 | — | — | EP | claimed |
| EP-3846783-B1 | NANOPARTICLES COMPRISING TACROLIMUS | LEON NANODRUGS GMBH (DE) | 2023-10-18 | — | — | EP | claimed |
| EP-3826627-B1 | ORALLY ADMINISTERABLE PHARMACEUTICAL DOSAGE FORM WITH MODIFIED RELEASE | BAYER AG (DE) | 2023-10-18 | — | — | EP | claimed |
| EP-3958344-B1 | BINDER RESIN COMPOSITION AND SEPARATOR FOR ELECTROCHEMICAL DEVICE COMPRISING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2023-09-27 | — | — | EP | claimed |
| EP-3996688-B1 | PHARMACEUTICAL PREPARATION | MERCK PATENT GMBH (DE) | 2023-09-06 | — | — | EP | claimed |
| EP-3281626-B1 | SOLUBLE MICRONEEDLE FOR DELIVERING POORLY-SOLUBLE DRUG | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2023-08-23 | — | — | EP | claimed |
| EP-0289977-B1 | SUSTAINED-RELEASE ORAL ADMINISTRATION FORMS | CIBA-GEIGY AG (CH) | 1993-09-15 | — | — | EP | claimed |
| EP-0557489-A1 | COMPOSITION PROVIDING A LASTING COSMETIC AND/OR PHARMACEUTICAL TREATMENT OF THE UPPER EPIDERMAL LAYERS BY TOPICAL APPLICATION ON THE SKIN. | OREAL (FR) | 1993-09-01 | — | — | EP | claimed |
| WO-1993005753-A1 | COMPOSITION PROVIDING A LASTING COSMETIC AND/OR PHARMACEUTICAL TREATMENT OF THE UPPER EPIDERMAL LAYERS BY TOPICAL APPLICATION ON THE SKIN | L'OREAL (FR) | 1993-04-01 | — | — | WO | claimed |
| EP-0248062-B1 | MEDICAMENTS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1992-05-06 | — | — | EP | claimed |
| EP-0277092-B1 | THERAPEUTIC SYSTEM FOR SLIGHTLY SOLUBLE ACTIVE INGREDIENTS | CIBA-GEIGY AG (CH) | 1992-01-29 | — | — | EP | claimed |
| EP-0165397-B1 | HAIR CARE COMPOSITIONS | Revlon, Inc. (US) | 1991-07-17 | — | — | EP | claimed |
| EP-0248047-B1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1991-06-19 | — | — | EP | claimed |
| EP-0164967-B1 | PHARMACEUTICAL COMPOSITION OF SPARINGLY SOLUBLE MEDICAMENT AND METHOD FOR ITS PREPARATION | STERWIN AG. (CH) | 1990-09-12 | — | — | EP | claimed |
| EP-0213999-B1 | COSMETIC COMPOSITION OBTAINED FROM CONNECTIVE TISSUE CELL CULTURES | Seguin, Marie-Christine (MC) | 1990-01-03 | — | — | EP | claimed |
| EP-0213999-A1 | Cosmetic composition obtained from connective tissue cell cultures | Seguin, Marie-Christine (MC) | 1987-03-11 | — | — | EP | claimed |